Life Summary
Chung Yong-ji is the CEO of Caregen and also serves as Chairman of the Board.

He is aiming to develop pharmaceuticals using peptide technology.

He was born in February 1970.

He graduated from the Department of Genetic Engineering at Sungkyunkwan University and earned a master's degree in Biochemistry from the University of Texas at San Antonio. He received a Ph.D. in Molecular Biology (Animal Science) from Cornell University.

In 2001, he founded Caregen, a company specializing in peptide-based cosmetics and fillers.

In 2021, he signed a global exclusive agreement with BASF, a global chemical company, to supply cosmetic peptides.

He is expanding beyond cosmetics into the bio field, focusing on the development of treatments for COVID-19, macular degeneration, and diabetes.

#ChungYongji #Caregen #PeptideTechnology #Biotech #CosmeticPeptides #COVID19Treatment #MacularDegeneration #DiabetesTreatment #PharmaceuticalDevelopment #BASFPartnership